Conflict of interest declaration: Robert J Boyle

Roles in: Skin Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
No

c) Fees for organising education?
No

d) Funds for research?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - In 2017 I received a consultancy fee for my role in a project funded by the Dairy Goat Cooperative, who manufacture infant formula milk. The project involved design of a clinical trial which fully supported breastfeeding in potential trial participants.

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - I participated in an advisory boards for ALK-Abello, who market allergen immunotherapy products, in 2017. I participated in an advisory board for DBV Technologies, who have developed a treatment for food allergy, in 2018. I participated in an advisory board for Prota Therapeutics, who have developed a treatment for food allergy, in 2019. My employing institution, Imperial College London, has a research and innovation partnership with Nestle, who market infant formula milk. I am not directly involved in this partnership.